Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Arylacetamides as AMP-activated protein kinase inhibitors and their use for treatment of breast cancer

Arylacetamides as AMP-activated protein kinase inhibitors and their use for treatment of breast cancer

US Patent 11479536 · Granted Oct 25, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2-aminomethylimidazole mimics of NS4A and their effect thereof on hepatitis C vi2025
2-(5-aminopyridin-2-yl)-N-benzylacetamides and use thereof in the treatment of a2025
2-(5-aminopyridin-2-yl)-N-benzylacetamides and use thereof in the treatment of a2025
Aryl-1,2,3-triazole compounds, pharmaceutical composition thereof and method for2025
Sulfonylhydrazide derivatives as anticancer agents2025
Benzaldehyde compounds with direct polymer destabilizing effects to treat sickle2024
Cleansing adsorption bed utilizing metal-organic framework2024
Potent antimicrobial compounds with a pyridazine nucleus2023
Potent antimicrobial compounds with a pyridazine nucleus2023
3-vinylquinolines as cancer cells inhibitors2022
Method for treating stomach cancer2022
Method for treating stomach cancer2022